Eversept Partners’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-181,961
Closed -$4.45M 74
2024
Q2
$4.45M Buy
+181,961
New +$4.45M 0.3% 45